-Live Mint Some commentators dismiss the seriousness of India's nutritional crisis as it fails to account for genetic differences With one in two children malnourished in India, child malnutrition is considered to be among the biggest challenges facing the country. But are these figures highly exaggerated? The answer is a resounding yes, according to Columbia University economist Arvind Panagariya, who believes that the international standards used to measure nutritional attainments of...

-Economic and Political Weekly The Saradha group's collapse has possibly bankrupted lakhs of small investors robbing them of their life svaings, and has rendered thousands of its agents jobless. The scam highlights the failure of the government and its regulatory agencies to reign in the mushrooming chit fund companies in West Bengal. It also brings under the scanner the Trinamool Congress' proximity with the tainted group. In the wake of the...

Guess what is the total percentage of dalit or tribal members in the boards of big Indian private and public sector companies listed on the stock exchange? Well, shocking as it might be, the real count is nearly zero. A fresh study conducted by D Ajit, Han Donker and Ravi Saxena reveals that at a time when the issues of ethnic and racial inequalities is being discussed all over the world,...

-Economic and Political Weekly The Supreme Court judgment on the Novartis-Glivec case is remarkable because it has gone beyond the specific technical and legal issues surrounding patents and has put the matter in a much larger political and economic perspective. The deeper implication of the judgment is that it is not only justified to deny patents when incremental innovation is trivial as in the Glivec case. The judgment has linked the...

-Economic and Political Weekly While the Supreme Court decision in the recent Novartis case has cleared the way for production of generic drugs in India, doctors have to prescribe cheaper alternatives to costly brands if patients with limited means are to benefit. What is being hailed as a victory in the struggle for affordable medicines in the country will actually be one only when there is a pro-patient slant to the...